Publication:
Phase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)

Simple item page
dc.conference.dateSEP 09-13, 2022
dc.conference.locationELECTR NETWORK
dc.conference.organizerAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.coauthorNomak, G.
dc.contributor.coauthorOksuzoglu, B.
dc.contributor.coauthorSenturk, R.
dc.contributor.coauthorEralp, Y.
dc.contributor.coauthorNomak, H.
dc.contributor.coauthorSanyal, R.
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorOrer, Hakan S.
dc.contributor.kuauthorYumuk, Perran Fulden
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-10T00:00:43Z
dc.date.issued2022
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipRS Research RS Research.
dc.description.studentonlypublicationNo
dc.description.studentpublicationNo
dc.description.versionN/A
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.annonc.2022.07.1876
dc.identifier.eissn1569-8041
dc.identifier.embargoN/A
dc.identifier.issn0923-7534
dc.identifier.issue7
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2022.07.1876
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15853
dc.identifier.volume33
dc.identifier.wos000866211601462
dc.keywordsNovel tumor
dc.keywordsDocetaxel
dc.keywordsMetastatic
dc.keywordsNon-small cell lung cancer
dc.language.isoeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofAnnals of Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectOncology
dc.subjectMedicine
dc.titlePhase Ia/Ib study of RS-0139, a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer (NSCLC)
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorOrer, Hakan S.
local.contributor.kuauthorYumuk, Perran Fulden
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext